GALECTIN THERAPEUTICS INC — Director's Dealing 2012

May 25, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GALECTIN THERAPEUTICS INC (GALT)
CIK: 0001133416
Period of Report: 2012-05-23

Reporting Person: TRABER PETER G (Director, CEO and President)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-05-23	Employee Stock Option (right to buy)	$2.08	A	420000	Acquired	2022-05-23	Common Stock (420000)	Direct

Footnotes

F1: The options vest as follows: 120,000 on May 23, 2012 (date of grant), and 100,000 on the first, second and third anniversaries of the date of grant.